Back to search

Article

IRW prevents diet-induced non-alcoholic fatty liver disease by preserving mitochondrial content and enhancing hepatic fatty acid oxidation capacity

2023-08-09

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) the hepatic manifestation of the metabolic syndrome, remains without approved pharmacological treatment, with lifestyle modifications being the first line of therapy. Alternative approaches, including food-derived bioactive peptides can aid in the management of metabolic conditions including hypertension, obesity and insulin resistance. IRW is a tripeptide produced from th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8bb6a7c4-57fb-521e-9606-7b6ebbe7ee02
DOI
10.21203/rs.3.rs-3228961/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
IRW prevents diet-induced non-alcoholic fatty liver disease by preserving mitochondrial content and enhancing hepatic fatty acid oxidation capacityDOI 10.21203/rs.3.rs-3228961/v1
Select a neighboring publication to make it the new centre.